SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-06-046173
Filing Date
2006-11-09
Accepted
2006-11-09 14:34:47
Documents
10
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 v056711_10q.htm 10-Q 729055
2 GRAPHIC logo.jpg GRAPHIC 9937
3 GRAPHIC logo_s.jpg GRAPHIC 1203
4 v056711_ex10-3.htm EX-10.3 196744
5 v056711_ex10-4.htm EX-10.4 118117
6 v056711_ex10-43.htm EX-10.43 168265
7 v056711_ex31-1.htm EX-31.1 12739
8 v056711_ex31-2.htm EX-31.2 13036
9 v056711_ex32-1.htm EX-32.1 6133
10 v056711_ex32-2.htm EX-32.2 5971
  Complete submission text file 0001144204-06-046173.txt   1267146
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 061201333
SIC: 2834 Pharmaceutical Preparations